World health organization grade II gliomas and subventricular zone: Anatomic, genetic, and clinical considerations

Neurosurgery

Volumn 68, Issue 5, 2011, Pages 1293-1298

  Vergani, Francesco ^a   Martino, Juan ^b   Gozé, Catherine ^c,d   Rigau, Valérie ^e   Duffau, Hugues ^d,e  

^a NEWCASTLE UPON TYNE HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

^d HÔPITAL SAINT ELOI   (France)

^e GUI DE CHAULIAC HOSPITAL   (France)

Author keywords

1p19q deletion; Subventricular zone; Surgery; WHO grade II glioma

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; BRAIN CORTEX; CANCER GRADING; CANCER INCIDENCE; CANCER SIZE; CANCER SURGERY; CHROMOSOME 1P; CLINICAL ARTICLE; DIFFUSION WEIGHTED IMAGING; FEMALE; GENE DELETION; GENETIC ANALYSIS; GLIOMA; HUMAN; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SUBVENTRICULAR ZONE; WORLD HEALTH ORGANIZATION;

ADULT; AGED; BRAIN NEOPLASMS; CEREBRAL VENTRICLES; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; STEM CELLS; WORLD HEALTH ORGANIZATION; YOUNG ADULT;

EID: 79955021796     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31820b522a     Document Type: Article

References (41)

1. Alvarez-Buylla A, Garcia-Verdugo JM. Neurogenesis in adult subventricular zone. JNeurosci. 2002;22(3):629-634. (Pubitemid 34141742)
2. Sanai N, Tramontin AD, Quinones-Hinojosa A, et al. Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration. Nature. 2004;427(6976):740-744. (Pubitemid 38294593)
3. Sanai N, Alvarez-Buylla A, Berger MS. Neural stem cells and the origin ofgliomas. N Engl J Med. 2005;353(8):811-822.
4. Uchida K, Mukai M, Okano H, Kawase T. Possible oncogenicity ofsubventricular zone neural stem cells: case report. Neurosurgery. 2004;55(4):977-978. (Pubitemid 39315047)
5. Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006;6(6):425-436.
6. Lim DA, Cha S, Mayo MC, et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. Neuro Oncol. 2007;9(4):424-429.
7. Wang Y, Yang J, Zheng H, et al. Expression ofmutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell. 2009;15(6):514-526.
8. Alcantara Llaguno S, Chen J, Kwon CH, et al. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell. 2009;15(1):45-56.
9. Kujas M, Lejeune J, Benouaich-Amiel A, et al. Chromosome 1p loss: a favorable prognostic factor in low-grade gliomas. Ann Neurol. 2005;58(2):322-326. (Pubitemid 41098891)
10. Ricard D, Kaloshi G, Amiel-Benouaich A, et al. Dynamic history of low-grade gliomas before and after temozolomide treatment. Ann Neurol. 2007;61 (5):484-490. (Pubitemid 46878776)
11. Laigle-Donadey F, Martin-Duverneuil N, Lejeune J, et al. Correlations between molecular profile and radiologic pattern in oligodendroglial tumors. Neurology. 2004;63(12):2360-2362. (Pubitemid 40024350)
12. Gozé C, Rigau V, Gibert L, Maudelonde T, Duffau H. Lack ofcomplete 1p19q deletion in a consecutive series of 12 WHO grade II gliomas involving the insula: a marker of worse prognosis? J Neurooncol. 2009;91(1):1-5.
13. Duffau H, Capelle L, Denvil D, et al. Usefulness of intraoperative electrical subcortical mapping during surgery for low-grade gliomas located within eloquent brain regions: functional results in a consecutive series of 103 patients. JNeurosurg. 2003;98(4):764-778. (Pubitemid 36396778)
14. Duffau H, Lopes M, Arthuis F, et al. Contribution ofintraoperative electrical stimulations in surgery of low grade gliomas: a comparative study between two series without (1985-96) and with (1996-2003) functional mapping in the same institution. J Neurol Neurosurg Psychiatry. 2005;76(6):845-851. (Pubitemid 40805817)
15. Duffau H, Gatignol P, Mandonnet E, et al. New insights into the anatomo-functional connectivity of the semantic system: a study using cortico-subcortical electrostimulations. Brain. 2005;128(pt 4):797-810. (Pubitemid 40516917)
16. Duffau H, Gatignol P, Mandonnet E, Capelle L, Taillandier L. Intraoperative subcortical stimulation mapping of language pathways in a consecutive series of 115 patients with hrade II glioma in the left dominant hemisphere. J Neurosurg. 2008;109(3):461-471.
17. Louis DN, Ohgaki H, Wiestler OD. WHO Classification ofTumours ofthe Central Nervous System. Lyon, France: IARC; 2007.
18. Mandonnet E, Delattre JY, Tanguy ML, et al. Continuous growth ofmean tumor diameter in a subset ofgrade II gliomas. Ann Neurol. 2003;53(4):524-528. (Pubitemid 36373265)
19. Berger MS, Deliganis AV, Dobbins J, Keles GE. The effect ofextent ofresection on recurrence in patients with low grade cerebral hemisphere gliomas. Cancer. 1994;74(6):1784-1791. (Pubitemid 24301834)
20. Galli R, Binda E, Orfanelli U, et al. Isolation and characterization oftumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64(19):7011-7021. (Pubitemid 39331011)
21. Barami K, Sloan AE, Rojiani A, et al. Relationship ofgliomas to the ventricular walls. J Clin Neurosci. 2009;16(2):195-201.
22. Mandonnet E, Capelle L, Duffau H. Extension ofparalimbic low grade gliomas: toward an anatomical classification based on white matter invasion patterns. JNeurooncol. 2006;78(2):179-185. (Pubitemid 44339686)
23. Costa MR, Kessaris N, Richardson WD, Götz M, Hedin-Pereira C. The marginal zone/layer I as a novel niche for neurogenesis and gliogenesis in developing cerebral cortex. JNeurosci. 2007;27(42):11376-11388. (Pubitemid 47621309)
24. Nunes MC, Roy NS, Keyoung HM, et al. Identification and isolation of mul-tipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med. 2003;9(4):439-447. (Pubitemid 36460078)
25. Lindberg N, Kastemar M, Olofsson T, Smits A, Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene. 2009;28(23):2266-2275.
26. McTigue DM, Tripathi RB. The life, death, and replacement ofoligodendrocytes in the adult CNS. JNeurochem. 2008;107(1):1-19.
27. Stiles CD, Rowitch DH. Glioma stem cells: a midterm exam. Neuron. 2008;58(6):832-846. (Pubitemid 351842757)
28. Vergani F, Sanson M, Duffau H. Combined multiple surgical intervention and chemotherapy for multicentric WHO grade II glioma: a long-term follow-up study. Acta Neurochir (Wien). 2009;151(12):1699-1704.
29. Augustine JR. Circuitry and functional aspects of the insular lobe in primates including humans. Brain Res Brain Res Rev. 1996;22(3):229-244. (Pubitemid 26390178)
30. Duffau H, Capelle L, Lopes M, et al. The insular lobe: physiopathological and surgical considerations. Neurosurgery. 2000;47(4):801-810.
31. Zlatescu MC, TehraniYazdi A, Sasaki H, et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res. 2001;61(18):6713-6715. (Pubitemid 32896492)
32. Mueller W, Hartmann C, Hoffmann A, et al. Genetic signature of oligoas-trocytomas correlates with tumor location and denotes distinct molecular subsets. Am J Pathol. 2002;161(1):313-319. (Pubitemid 34760797)
33. Mariani L, Deiana G, Vassella E, et al. Loss of heterozygosity 1p36 and 19q13 is a prognostic factor for overall survival in patients with diffuse WHO grade 2 gliomas treated without chemotherapy. J Clin Oncol. 2006;24(29):4758- 4763. (Pubitemid 46630940)
34. Duffau H. Lessons from brain mapping in surgery for low-grade glioma: insights into associations between tumour and brain plasticity. Lancet Neurol. 2005;4(8):476-486. (Pubitemid 40982458)
35. Desmurget M, Bonnetblanc F, Duffau H. Contrasting acute and slow-growing lesions: a new door to brain plasticity. Brain 2007;130(Pt 4):898-914. (Pubitemid 47355582)
36. Duffau H. New concepts in surgery ofWHO grade II gliomas: functional brain mapping, connectionism and plasticity: a review. J Neurooncol. 2006;79(1): 77-115. (Pubitemid 44057422)
37. Smith JS, Perry A, Borell TJ, et al. Alterations ofchromosome arms 1p and 19q as predictors of survival in oligodendrogliomas, astrocytomas, and mixed oligoas-trocytomas. J Clin Oncol. 2000;18(3):636-645. (Pubitemid 30078545)
38. Hoang-Xuan K, Capelle L, Kujas M, et al. Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions. J Clin Oncol. 2004;22(15):3133-3138. (Pubitemid 41103727)
39. Kaloshi G, Benouaich-Amiel A, Diakite F, et al. Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology. 2007;68(21):1831-1836. (Pubitemid 46791397)
40. Smith JS, Chang EF, Lamborn KR, et al. Role of extent of resection in the long-term outcome oflow-grade hemispheric gliomas. JClin Oncol. 2008;26(8): 1338-1345.
41. Duffau H. Surgery oflow-grade gliomas: towards a "functional neurooncology". Curr Opin Oncol. 2009;21(6):543-549.